Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

DaVita Inc. (DVA)

NYQ · Medical Care Facilities

$239.46+3.15 (+1.33%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$15.37B
P/E (TTM)
23.09
EPS
$10.37
Div Yield
52W Range
$101.00–$241.73
Beta
0.88

Company overview

Next earnings: 2026-08-04(7d)

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Peers in Medical Care Facilities

All in industry →

Recent press releases

April 2026

3 months agoARSHealthcare

DAVITA Inc. Requires Content to Complete ARS Financial Summary

DVADAVITA INC.

⚠️ **🛑 ATTENTION: MISSING DOCUMENT CONTENT 🛑** I am an expert financial analyst and educator and am fully prepared to generate the comprehensive, highly detailed, and conversational summary you requested! However, the source material provided is empty (`<PDF></PDF>`). To summarize DAVITA INC.'s

Read summaryView on SEC EDGAR
3 months agoDEF 14AHealthcare

DaVita presents governance blueprint detailing board oversight and structure

DVADAVITA INC.

***Disclaimer: This summary is based solely on the provided text from the SEC filing and is for educational purposes only. It does not constitute financial advice.*** # 📄 Proxy Statement 📜 What This Document Is This is a definitive Proxy Statement (Form DEF 14A) filed by DaVita Inc. 🗓️. A Proxy

Read summaryView on SEC EDGAR

SEC filings

All filings →
2 recent filings shown in the timeline above. View all SEC filings →

DaVita Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
31,759,065 sh-1.2%
2,926,392 sh-18.2%
4,154,354 sh-1.7%
1,438,488 sh-21.6%
259,132 sh-62.3%
541,032 sh+585.0%
432,748 sh+758.9%

People at DaVita Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
-$11.7M
NI $162.9M
06/25
$2.91B
NI $199.3M
09/25
$3.42B
NI $150.3M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $2.04
Prior: $2.58
Revenue sparkline